Image

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

Testing INDV-2000 for moderate to severe opioid addiction treatment.

Recruiting
18-65 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new drug called INDV-2000 for people with moderate to severe Opioid Use Disorder (OUD). Opioids are strong drugs that can cause addiction, and OUD is when someone has a hard time stopping their use despite problems it causes. This study is for adults who have just started or finished a short-term withdrawal program using a medicine called buprenorphine, which helps with withdrawal symptoms. The goal is to see if INDV-2000 is safe and effective in reducing opioid use without using other opioids.

Participants will take buprenorphine and either INDV-2000 or a placebo (a pill that doesn't contain medicine) for the first 7 days. After that, they will continue with INDV-2000 or placebo alone. The study aims to find the right dose of INDV-2000 that works best.

  • The study requires participants to be between 18-65 years old.
  • It includes several visits to the clinic for check-ups and monitoring.
  • Participants must not have other severe health issues or recent opioid overdose.
Print
Study details
    Opioid Use Disorder

NCT06384157

Indivior Inc.

8 February 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.